Form 4: Alignment Healthcare CEO Sells Shares for Tax Obligations

Alignment Healthcare CEO John E. Kao sold shares to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• John E. Kao, Chief Executive Officer and Director of Alignment Healthcare, Inc. (ALHC), reported transactions on March 12, 2026.
• Kao sold a total of 48,899 shares of common stock in two separate transactions.
• The first transaction involved the sale of 45,938 shares at a weighted-average price of $17.476 per share, with prices ranging from $17.035 to $18.03.
• The second transaction involved the sale of 2,961 shares at a weighted-average price of $16.9919 per share, with prices ranging from $16.92 to $17.03.
• These sales were non-discretionary, executed solely to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following these transactions, Kao directly beneficially owns 1,519,480 shares and indirectly owns 2,472,641 shares through the JEK Trust, dated February 8, 2021, of which he is the trustee.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and solely for tax withholding, which is a common occurrence for executives receiving equity compensation.

Positives

• The sale was not a discretionary trade by the reporting person, indicating it was not driven by a negative outlook on the company's future performance.

Negatives

• A reduction in direct beneficial ownership by the CEO, though for tax purposes, slightly decreases insider alignment.

Future Outlook

NA

Management Comments

• Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that routine insider sales for tax purposes, especially related to restricted stock unit (RSU) vesting, are common across industries and typically do not signal a change in management's confidence or company fundamentals. Such sales are often pre-scheduled under Rule 10b5-1 plans.

Comparison to Industry Standards

• Routine tax-related sales by executives are standard practice across publicly traded companies globally. For example, executives at tech giants like Apple or healthcare companies like UnitedHealth Group frequently execute similar non-discretionary sales upon RSU vesting to cover tax liabilities, which is a normal part of executive compensation structures.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the non-discretionary nature for tax purposes suggests no change in management's confidence or the company's strategic direction.

Key Dates

Recommendation

The filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations from RSU vesting. This type of transaction is common and does not indicate a change in the company's fundamentals or management's outlook. Therefore, it provides no new information to warrant a change from a 'hold' position based solely on this filing.

Keywords

Alignment Healthcare, ALHC, John E. Kao, Insider Trading, Form 4, Stock Sale, CEO, Restricted Stock Units, Tax Withholding